Insider Buying and Selling - IMNM

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
11/22/2024	11/25/2024	Siegall Clay B President and CEO CEO Director	Buy	33,943 @ $9.78	$331,918.41	519,636	(6.99%)	Direct
11/21/2024	11/25/2024	Lechleider Robert Chief Medical Officer Officer	Buy	15,805 @ $9.48	$149,799.79	15,805	(100.00%)	Direct
11/21/2024	11/25/2024	Siegall Clay B President and CEO CEO Director	Buy	66,057 @ $9.54	$630,263.05	485,693	(15.74%)	Direct
11/21/2024	11/25/2024	Tsai Philip Chief Technology Officer Officer	Buy	21,000 @ $9.43	$198,030.00	21,000	(100.00%)	Direct
08/16/2024	08/19/2024	Bienaime Jean Jacques Director	Buy	7,000 @ $13.94	$97,608.00	16,615	(72.80%)	Direct
05/21/2024	05/22/2024	Bienaime Jean Jacques Director	Buy	2,000 @ $13.57	$27,139.80	9,615	(26.26%)	Direct
05/21/2024	05/21/2024	Siegall Clay B President and CEO CEO Director	Buy	20,434 @ $13.78	$281,547.83	419,636	(5.12%)	Direct
05/20/2024	05/21/2024	Siegall Clay B President and CEO CEO Director	Buy	79,566 @ $13.91	$1,106,524.36	399,202	(24.89%)	Direct

Immunome Inc. - IMNM